Soluble CD14 Subtype-A New Biomarker in Predicting the Outcome of Critically Ill Septic Patients

Presepsin revealed an optimal prognostic performance in patients with severe sepsis and provided interesting diagnostic value. Prediction of outcome in critically ill patients is crucial to optimize management decisions and level of treatment.